CoChat

Intracellular Inclusions Containing Mutant α1-Antitrypsin Z Are Propagated in the Absence of Autophagic Activity

Open access

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Mutant alpha(1)-antitrypsin Z (alpha(1)-ATZ) protein, which has a tendency to form aggregated polymers as it accumulates within the endoplasmic reticulum of the liver cells, is associated with the development of chronic liver injury and hepatocellular carcinoma in hereditary alpha(1)-antitrypsin (alpha(1)-AT) deficiency. Previous studies have suggested that efficient intracellular degradation of alpha(1)-ATZ is correlated with protection from liver disease in alpha(1)-AT deficiency and that the ubiquitin-proteasome system accounts for a major route, but not the sole route, of alpha(1)-ATZ disposal. Yet another intracellular degradation system, autophagy, has also been implicated in the pathophysiology of alpha(1)-AT deficiency. To provide genetic evidence for autophagy-mediated disposal of alpha(1)-ATZ, here we used cell lines deleted for the Atg5 gene that is necessary for initiation of autophagy. In the absence of autophagy, the degradation of alpha(1)-ATZ was retarded, and the characteristic cellular inclusions of alpha(1)-ATZ accumulated. In wild-type cells, colocalization of the autophagosomal membrane marker GFP-LC3 and alpha(1)-ATZ was observed, and this colocalization was enhanced when clearance of autophagosomes was prevented by inhibiting fusion between autophagosome and lysosome. By using a transgenic mouse with liver-specific inducible expression of alpha(1)-ATZ mated to the GFP-LC3 mouse, we also found that expression of alpha(1)-ATZ in the liver in vivo is sufficient to induce autophagy. These data provide definitive evidence that autophagy can participate in the quality control/degradative pathway for alpha(1)-ATZ and suggest that autophagic degradation plays a fundamental role in preventing toxic accumulation of alpha(1)-ATZ.

Overview

Integrity signals

Registry

Crossref · 10.1074/jbc.m509409200

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 4

  1. Teckman, 1996, Hepatology, 24, 1504
  2. Teckman, 2000, Am. J. Physiol., 278, G39
  3. Teckman, 2002, Am. J. Physiol., 283, G1156
  4. Teckman, 2004, Am. J. Physiol., 286, G851

Cited by

See all 260

Metadata

Authors
Kamimoto, T., Shoji, S., Hidvegi, T., Mizushima, N., Umebayashi, K., Perlmutter, D. H., & Yoshimori, T.
Affiliations
  • National Institute of Genetics (JP)
  • University of Pittsburgh (US)
  • National Institute for Basic Biology (JP)
Corresponding author
Yoshimori, Tamotsu
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2006-02
Volume
281
Issue
7
Pages
4467-4476
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2014500807
Cited by
259
References
41
Citations by year
2026: 2 · 2025: 3 · 2024: 6 · 2023: 4 · 2022: 6 · 2021: 16 · 2020: 10 · 2019: 9 · 2018: 13 · 2017: 6 · 2016: 13 · 2015: 12 · 2014: 21 · 2013: 19 · 2012: 14
FWCI
13.45
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01dk061760-05)
  • National Heart, Lung, and Blood Institute (HL037784, R01HL037784)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-061760, DK52565)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
Keywords
alpha-1 antitrypsin deficiency, autophagy, protein degradation, ATG5, GFP-LC3, autophagosome-lysosome fusion, protein quality control, hepatocellular carcinoma, chronic liver injury, transgenic mouse model
MeSH terms
Autophagy-Related Protein 5, alpha 1-Antitrypsin, Animals, Autophagy, Cells, Cultured, Inclusion Bodies, Endoplasmic Reticulum, Microtubule-Associated Proteins, Mutation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.